The Beauté Group Secures UK Distribution Rights for INDIBA Beauty & Aesthetics
The Beaute Group is proud to announce that we have secured the exclusive UK distribution
rights for INDIBA Beauty & Aesthetics, strengthening our position within the growing
radiofrequency and aesthetics UK markets.
This partnership represents more than an expansion of our portfolio, it is a strategic move
aligned with our long-term vision to build a clinically credible, regenerative led advanced
beauty and aesthetics technology UK clinics can trust.
Why INDIBA?
INDIBA is globally recognised for its science-backed radiofrequency technology, trusted across aesthetics, rehabilitation, and performance medicine. As demand for premium radiofrequency treatments begins to rise across the UK, clinics are looking for technology that goes beyond surface-level tightening and supports measurable biological repair.
INDIBA’s proprietary system works at a cellular level to support:
● Tissue repair
● Circulation enhancement
● Inflammation regulation
● Collagen stimulation
● Long-term structural integrity
This goes beyond cosmetic-level integration.
It is regenerative infrastructure designed to work with the body’s biology, a critical evolution
in radiofrequency in the UK aesthetics industry.
Strengthening the Beauté Group Ecosystem
At the Beauté Group, we are building more than brands. We are building interconnected systems.
With LumiSKN Devices, we focus on commercially intelligent aesthetic platforms.
With LumiSKN Clinics, we deliver results-led & longevity focused treatments.
With Skin United, we prioritise diagnostics and education.
By securing INDIBA, we elevate our offering within the Radiofrequency sector, reinforcing our commitment to advanced regenerative models rather than short term aesthetic trends. Each division addresses a different aspect of sustainable skin and tissue health. Together, they create a scalable ecosystem for clinics across the UK seeking leadership and advanced beauty and aesthetics technology.
The Shift Towards Regenerative Aesthetics
The aesthetics industry is growing rapidly. Clients are increasingly aware of recovery, inflammation, and long-term tissue health. They are asking more informed questions. They expect more than temporary correction. The future of radiofrequency aesthetics lies in regeneration, not reaction. When clinically validated RF technology is integrated correctly, it supports the internal environment required for stronger outcomes, improved healing, and longer-lasting results. This is why INDIBA represents such a pivotal addition to our portfolio.
What This Means For UK Clinics
Through this partnership, aesthetic businesses and skin clinics will will gain access to:
● Globally recognised radiofrequency systems
● Structured training and implementation support
● Integration into longevity-led clinic models
● Commercial guidance for scaling premium RF treatments and services.
We are committed to ensuring INDIBA is positioned within a structured framework that supports growth within the competitive radiofrequency and regenerative aesthetics landscape. Technology alone is not enough. It must be embedded into intelligent systems.
Looking Ahead
Recovery, inflammation control and biological optimisation are becoming central pillars of
modern aesthetics.
By securing UK distribution rights for INDIBA, The Beauté Group continues to lead within the advanced aesthetics and longevity industries.
We are not building around trends.
We are building infrastructure for the future of the industry.
Further information on training, integration and national rollout will follow shortly.
Contact for any inquires.